Condition: Hemolytic Disease of the Fetus and Newborn · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to assess the effectiveness of nipocalimab when compared to placebo in decreasing the risk of fetal anemia (a condition in which a baby's red blood cell volume falls below normal levels while the baby is developing in the womb) with live neonates in pregnant participants at risk for severe hemolytic disease of the fetus and newborn.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| University of California at San Diego | La Jolla, California, United States | Recruiting |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles, California, United States | Recruiting |
| UC Davis School of Medicine | Sacramento, California, United States | Recruiting |
| Childrens Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
| Advocate Children's Hospital | Park Ridge, Illinois, United States | Recruiting |
| Riley Children s Hospital | Indianapolis, Indiana, United States | Recruiting |
| University of Kentucky Medical Center | Lexington, Kentucky, United States | Recruiting |
| Johns Hopkins Hospital | Baltimore, Maryland, United States | Recruiting |
| Midwest Fetal Care Center | Minneapolis, Minnesota, United States | Recruiting |
| Columbia University Medical Center | New York, New York, United States | Recruiting |
| University of North Carolina (UNC) - School of Medicine | Chapel Hill, North Carolina, United States | Recruiting |
+ 50 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05912517